VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Hangzhou DAC Biotech Signs Cross-Border ADC BD Deal with Whitehawk Therapeutics
Hangzhou DAC Biotech Signs Cross-Border ADC BD Deal with Whitehawk Therapeutics
May 22, 2026 13:15 CST Updated May 25, 15:35
Share:
WuXi Biologics
Contract Research, Development and Manufacturing Organization (CRDMO) Service Provider